Deferasirox for managing iron overload in patients with myelodysplastic syndrome
Información
- DOI:
- https://doi.org/10.1002/14651858.CD007461Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 08 octubre 2008see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Hematología
- Copyright:
-
- Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Joerg Meerpohl, together with Dirk Bassler, developed the protocol. Gerta Ruecker provided the statistical expertise. Gerd Antes, Charlotte Niemeyer, Claire McLeod and Nigel Fleeman gave valuable advice and approved the final version.
Sources of support
Internal sources
-
German Cochrane Center, Freiburg, Germany.
External sources
-
No sources of support supplied
Declarations of interest
Joerg Meerpohl enrolled two adolescents with thalassaemia and one with Diamond‐Blackfan anaemia in a post marketing surveillance study on deferasirox. None declared for other authors.
Acknowledgements
We thank Edith Motschall for providing advice on the search strategy and the reviewers for their valuable comments which helped us to improve the protocol. We would also like to thank the editorial team for the help in preparing this protocol.
Version history
| Published | Title | Stage | Authors | Version |
| 2014 Oct 28 | Deferasirox for managing iron overload in people with myelodysplastic syndrome | Review | Joerg J Meerpohl, Lisa K Schell, Gerta Rücker, Nigel Fleeman, Edith Motschall, Charlotte M Niemeyer, Dirk Bassler | |
| 2010 Nov 10 | Deferasirox for managing iron overload in people with myelodysplastic syndrome | Review | Joerg J Meerpohl, Gerd Antes, Gerta Rücker, Nigel Fleeman, Edith Motschall, Charlotte M Niemeyer, Dirk Bassler | |
| 2008 Oct 08 | Deferasirox for managing iron overload in patients with myelodysplastic syndrome | Protocol | Joerg J Meerpohl, Gerd Antes, Gerta Rücker, Claire McLeod, Nigel Fleeman, Charlotte Niemeyer, Dirk Bassler | |
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
Medical Subject Headings Check Words
Humans;
PICO
| No. | Search |
| #1 | deferasirox*.mp |
| #2 | (ICL670* or ICL 670*).mp |
| #3 | (CGP72670* or CGP 72670*).mp |
| #4 | exjade*.mp |
| #5 | 2‐hydroxyphenyl.mp |
| #6 | triazol‐1‐yl.mp |
| #7 | benzoic acid.mp |
| #8 | #5 and #6 and #7 |
| #9 | #1 or #2 or #3 or #4 or #8 |
| .mp | = Abstract (AB), Subject Heading Word (HW), |
| No. | Search |
| #1 | deferasirox*.mp |
| #2 | (ICL670* or ICL 670*).mp |
| #3 | (CGP72670* or CGP 72670*).mp |
| #4 | exjade*.mp |
| #5 | 2‐hydroxyphenyl.mp |
| #6 | triazol‐1‐yl.mp |
| #7 | benzoic acid.mp |
| #8 | #5 and #6 and #7 |
| #9 | #1 or #2 or #3 or #4 or #8 |
| mp | = Abstract (AB), Device Manufacturer (DM), Drug Manufacturer Name (MF), |
| No. | Search |
| #1 | deferasirox*.mp |
| #2 | (ICL670* or ICL 670*).mp |
| #3 | (CGP72670* or CGP 72670*).mp |
| #4 | exjade*.mp |
| #5 | 2‐hydroxyphenyl.mp |
| #6 | triazol‐1‐yl.mp |
| #7 | benzoic acid.mp |
| #8 | #5 and<#6 and #7 |
| #9 | #1 or #2 or #3 or #4 or #8 |
| mp | = Abstract (AB), Accession Number (AN), Author (AU), Drug Trade Name (TN) |
| No. | Search |
| #1 | deferasirox* (Topic) |
| #2 | (ICL670* or "ICL 670*") (Topic) |
| #3 | (CGP72670* or "CGP 72670*") (Topic) |
| #4 | exjade* (Topic) |
| #5 | 2‐hydroxyphenyl (Topic) |
| #6 | triazol‐1‐yl (Topic) |
| #7 | "benzoic acid" (Topic) |
| #8 | #5 and #6 and #7 |
| #9 | #1 or #2 or #3 or #4 OR #8 |
| No. | Search |
| #1 | deferasirox* (Topic) |
| #2 | (ICL670* or "ICL 670*") (Topic) |
| #3 | (CGP72670* or "CGP 72670*") (Topic) |
| #4 | exjade* (Topic) |
| #5 | 2‐hydroxyphenyl (Topic) |
| #6 | triazol‐1‐yl (Topic) |
| #7 | "benzoic acid" (Topic) |
| #8 | #5 and #6 and #7 |
| #9 | #1 or #2 or #3 or #4 OR #8 |
